We evaluated the evolving structure of radiation oncology in Japan in terms of equipment, personnel, patient load, and geographic distribution to identify and overcome any existing limitations. From March 2011 to June 2013, the Japanese Society for Radiation Oncology conducted a questionnaire based on the Japanese national structure survey of radiation oncology in 2010. Data were analyzed based on the institutional stratification by the annual number of new patients treated with radiotherapy per institution. The estimated annual numbers of new and total (new plus repeat) patients treated with radiation were 211 000 and 251 000, respectively. Additionally, the estimated cancer incidence was 805 236 cases, with 26.2% of all newly diagnosed patients being treated with radiation. The types and numbers of treatment devices actually used included linear accelerator (LINAC; n = 829), telecobalt (n = 9), Gamma Knife (n = 46), 60 Co remote afterloading system (RALS; n = 28), and 192 Ir RALS (n = 131). The LINAC system used dual-energy functions in 586 units, threedimensional conformal radiotherapy functions in 663, and intensity-modulated radiotherapy (IMRT) functions in 337. There were 564 JASTRO-certified radiation oncologists, 959.2 full-time equivalent (FTE) radiation oncologists, 1841.3 FTE radiotherapy technologists, 131.3 FTE medical physicists, 121.5 FTE radiotherapy quality managers, and 649.6 FTE nurses. The frequency of IMRT use significantly increased during this year. To conclude, although there was a shortage of personnel in 2010, the Japanese structure of radiation oncology has clearly improved in terms of equipment and utility.
PREFACE
We greatly appreciate the substantial contributions of the many radiation oncologists (ROs), radiation technologists, and other staff to the national structure survey of radiation oncology. Despite some delays, the updated Japanese national structure survey data for radiation oncology in 2010 is now available.
Since 1991, the Japanese Society for Radiation Oncology (JASTRO) has conducted national structure surveys every 2 years . From March 2011 to June 2013, the Japanese Society for Radiation Oncology conducted a questionnaire based on the Japanese national structure survey of radiation oncology in 2010, which included the number of treatment systems by type, number of personnel by category, and number of patients by type, site, and treatment modality. To measure variables over a longer time period, data for the year 2010 were also considered. In total, 705 of 780 active institutions attempted the survey; the response rate was 90.4%.
The current report analyzes these institutional structure data (equipment, personnel, patient load, and geographic distribution) based on institutional stratification according to the annual number of new patients treated with radiotherapy at each institution. The clinical working hours of each staff member performing radiotherapy were derived from full-time equivalent (FTE; 40 h per week for radiation oncology work only) data. The Japanese Blue Book Guidelines (JBBG) [25, 26] were used for comparison with the results of this study. These guidelines pertain to the structure of radiation oncology in Japan based on the Patterns of Care Study (PCS) [27, 28] data. The standard guidelines were set at 250-300 (warning level, 400) for annual patient load per external beam machine, at 200 (warning level, 300) for annual patient load per FTE RO, and at 120 (warning level, 200) for annual patient load per FTE radiotherapy technologist. Furthermore, we analyzed data from the designated cancer care hospitals accredited by the Ministry of Health, Labor, and Welfare. As at 1 August 2013, Japan had 397 designated cancer care hospitals [29] . Twenty-three institutions did not return the survey; therefore, the structure data for 374 designated cancer care hospitals were analyzed and compared with the data for all radiotherapy hospitals. The analysis was conducted in two groups: institutions with <1.0 FTE RO and those with ≥1.0 FTE RO.
Here, preliminary results have been presented as tables and figures (Tables 1-18 and Figs 1-6). We have briefly summarized the Japanese national structure survey of radiation oncology for 2010. In total, 780 radiotherapy institutions were surveyed, and the estimated number of new patients was~211 000; the estimated total number of patients (new plus repeat) was 251 000. In 2010, based on Japanese cancer registries, the cancer incidence was estimated at 805 236 cases [30] Approximately 50.0% of all radiotherapy institutions had >200 new radiotherapy patients per year, whereas 31.6% of the institutions had >300. Additionally, 47.5% of all radiotherapy institutions had <1.0 FTE ROs. We expect that this updated national structure survey of radiation oncology for 2010 will aid the continuous improvement of all aspects of radiation oncology in Japan.
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Ir RALS (in actual use) 0 (1) 8 (6) 21 (18) 20 (20) 17 (17) 70 (70) 136 (131) 137
Cs RALS (in actual use) [25] . Crosses and circles denote the estimated numbers of total (new plus repeat) and new patients, respectively, from the results in the structure surveys by the JASTRO. Water phantom (2 or more) 119 (17) 236 (41) 165 (41) 111 (29) 65 (17) 174 (44) 870 (189) Film densitometer (2 or more) 38 (1) 89 (1) 63 (2) 63 (4) 34 (2) 98 (14) 385 (24) Dosimeter (3 or more) 311 (56) 690 (130) 482 (80) 358 (59) 203 (33) 564 (78) 2 608 (436) The numbers in parentheses indicate the number of institutions. CT = computed tomography, RTP = radiotherapy planning, MRI = magnetic resonance imaging, RT = radiotherapy. Overlap is included in the total number of each staff (radiotherapy technologist, medical physicist, and radiotherapy quality manager). RT = radiotherapy, JRS = Japan Radiological Society, RO = radiation oncologist, JASTRO = Japanese Society for Radiation Oncology, FTE = full-time equivalent, RTT = radiotherapy technologist. IMRT = intensity-modulated radiotherapy, Sr = strontium, Y = yttrium. The total numbers of new patients in Table 3 differ from these data, because no data on primary sites were reported by some institutions. LINAC = linear accelerator, 3DCRT = three dimensional conformal radiotherapy, MLC = multileaf collimator, IMRT = intensity-modulated radiotherapy, CT = computed tomography. 
